Medical review network
The named reviewers who approve content on PsychiatryRx, and the specialist panels we are actively seeking. A reviewer's name only appears on a page they have actually reviewed and approved.
Interested in a broader editorial contribution than review alone — expert perspective sidebars, state-of-practice quotes, teaching examples, corrections, or aggregated data? See how to contribute.
Current reviewers
Every page on this site carries the reviewer's name and last-reviewed date. Reviewer profiles include credentials, area of expertise, financial disclosures, and the list of pages that reviewer approved.
Specialist panels: currently open
PsychiatryRx is actively seeking board-certified specialists to review focused subsets of the site. The goal is not decorative "medical reviewer" badges; it is genuine editorial governance in domains where subspecialty expertise sharpens the content.
If you are a board-certified specialist in one of these areas, we invite you to review the scope of content named below and contact us. Reviewers receive: a public profile page at /reviewers/<your-slug>/ containing your credentials, area of expertise, disclosures, and the list of pages you approved; a shareable reviewer badge you may embed on your own institutional or practice site; and named credit on every page you review.
Reviewers do not receive compensation, referral revenue, or any commercial relationship with the site.
-
Reproductive psychiatry
Board-certified psychiatrists with clinical or academic focus on preconception, pregnancy, postpartum, and lactation psychopharmacology.
Scope: The pregnancy-safety and postpartum-related guides; SSRI, SNRI, and atypical antidepressant pages where pregnancy or lactation considerations are prominent; the zuranolone and brexanolone state-of-practice pieces.
1 named seat open. · panel page →
-
Geriatric psychiatry
Board-certified psychiatrists or geriatricians with clinical focus on late-life mental health and geriatric psychopharmacology.
Scope: The Beers Criteria reference; the antidepressants-for-elderly and antipsychotics-for-elderly guides; the lecanemab and donanemab state-of-practice piece; anticholinergic burden guidance.
1 named seat open. · panel page →
-
Addiction psychiatry
Board-certified addiction psychiatrists with expertise in medications for opioid, alcohol, and stimulant use disorders.
Scope: MOUD-relevant medication pages (buprenorphine, methadone, naltrexone), acamprosate, disulfiram, varenicline, the alcohol-psych-meds interaction page, and the medications-for-opioid-use-disorder cheat sheet.
1 named seat open. · panel page →
-
Child and adolescent psychiatry
Board-certified child and adolescent psychiatrists.
Scope: Age-specific considerations on ADHD medication pages, SSRI use in pediatric populations, guanfacine and clonidine for pediatric ADHD, and the boxed-warning content on antidepressants in youth.
1 named seat open. · panel page →
-
Psychiatric pharmacy
Board-certified psychiatric pharmacists (BCPP) reviewing pharmacokinetics, interactions, and dosing tables.
Scope: The CYP450 interaction reference, half-life quick reference, renal and hepatic dosing guides, dose equivalence tables (CPZ, diazepam), taper planner, discontinuation-syndromes guide, and every interaction page.
1 named seat open. · panel page →
-
Metabolic monitoring
Board-certified endocrinologists, internists, or psychiatrists with focus on cardiometabolic side effects of psychotropics.
Scope: The metabolic monitoring schedule tool, the antipsychotic weight-gain content, glucose and lipid monitoring guidance, and the atypical antipsychotic class pages.
1 named seat open. · panel page →
Editorial safeguards
How we verify credentials, handle industry disclosures, and enforce recusal from conflicted content is documented publicly on the editorial safeguards page. Reviewers agree to these safeguards on joining.
To join a panel
Email [email protected] with the subject "Medical review network interest." Include your name, board certification, current practice or academic affiliation, any published work in the panel's scope, financial disclosures, and the panel(s) you would review. We will follow up with the specific pages we would ask you to approve and the timeline.
Every panel seat is filled with an actual reviewer who reviews at least one page in the panel's scope. We do not add reviewers who do not participate. Reviewers may step off a panel at any time; their profile page then notes their last participation date.
How PsychiatryRx decides what to publish, and how reviewers fit into that, is documented on the public editorial strategy and editorial process pages.